Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Wassil Nowicky

Wassil Nowicky

Ukrainian Anti-Cancer Institute Austria

Kakil Ibrahim Rasul

Kakil Ibrahim Rasul

National Center for Cancer Care and Research Qatar

Jae Pil Hwang

Jae Pil Hwang

Soonchunhyang University Hospital South Korea

Juan Pablo Marquez

Juan Pablo Marquez

Sonora Cancer Research Centre USA

Phung Thi Huyen

Phung Thi Huyen

Vietnam National Cancer Hospital Vietnam

Karlo Fidel

Karlo Fidel

Cardinal Santos Medical Center Philippines

Chiung-Fang Chang

Chiung-Fang Chang

Far Eastern Memorial Hospital Taiwan

Gordon Moffat

Gordon Moffat

SUNY Downstate Medical Center College of Medicine USA

Asia Pacific Oncologists 2019

About Conference


Asia Pacific Oncologists 2019 welcomes every one of the individuals over the globe to participate in "16th Asia-Pacific Oncologists Annual Meeting" slated during May 13-14, 2019 at Singapore.

Asia Pacific Oncologists 2019 coordinates addressing the principle themes and in addition inevitable methodologies of oncology. This will be the biggest and most important worldwide gathering in which the program incorporates Medical Oncologists, whole medicinal group required in the field of tumor to learn estimations of oncology and exceedingly branches of disease will come to examine and discuss on various parts of the malignancy, potential outcomes and genuine research work and finish confirmation of oncology. This gathering manages the one of a kind technique for oncology and its inventive procedures. The occasion is a two day program and the gathering topic is "Towards the Innovations in the Cancer Treatment" and from now on, we are looking for a support of cutting edge thoughts which frames the feeling of our Medical gatherings.

Why to attend???

Join your nobles around the world focused on learning about Oncology and related advances, which is your single best opportunity to reach the largest gathering of participants from the  community, conduct demonstrations, distribute information, meet with current and potential professionals, make a splash with a new research works, and receive name recognition at this 2 day event. World-renowned speakers, the most topical research, advances, and the newest updates in Oncology are hallmarks of this conference.

Target Audience:

  • Business Entrepreneurs Public
  • Health Professionals
  • Drug Manufacturing Companies
  • Radiation Therapist
  • Oncology Societies
  • Clinical Researchers
  • Leading world Doctors
  • Surgical and Medical Oncologists
  • Young Researchers
  • Students & Delegates

Sessions/Tracks

Conferenceseries invites all the participants across the globe to attend the “15th Asia-Pacific Oncologists Annual Meeting” slated on September 5-6, 2018 at Tokyo, Japan.

Asia Pacific Oncologists 2019 is a global platform to discuss and learn about Pathophysiology of Cancer, Neurological Cancer, Oral Cancer, Skin cancer, Blood and Bone Cancer, Lung cancer, renal cancer, Breast Cancer, Pancreatic and colorectal cancer, Reproductive Cancers, Cancer Therapy, Cancer Screening & Diagnosis and Cancer: Innovations and Nursing Oncology.

Track 1: Pathophysiology of Cancer:

One of the initial phases in a solid cell turning into a disease cell is the difference in the proto-oncogens to oncogenes. Proto-oncogenes are qualities that are coded to keep up typical cell development. Oncogenes are a quality that has changed to influence the cells to develop and isolate quicker. In growth cells the cell develops and separates rapidly. The second means to turning into a malignancy cell is the tumor silencer qualities get killed. Tumor silencer qualities are a piece of a solid cell’s DNA that assistance prevent disease from shaping in sound cells. Tumor silencer qualities help back off cell development, when these qualities are killed the cell with develop and isolate rapidly. The last advance to turning into a Cancer cell is the DNA repair qualities gets killed. DNA repair qualities enable your sound cells to know whether something isn't right with its DNA and how to settle it. At the point when these qualities get killed the cell doesn't know whether it is wiped out, and it can't settle any issues with its DNA.

Related Conferences: Oncology Symposium | Oncology Conferences | Oncology Meetings | Oncology Congress  | Cancer Conferences | Oncologists Meetings

Euro Congress on Cancer Science & Cancer Therapy during March 07-08, 2019 at Barcelona, Spain; World Conference on Medical Oncology & Hematology during March 27-28, 2019 at Hong Kong; World Congress on Neonatal & Pediatric Oncology during April 1-2, 2019 at Auckland, New Zealand; Global Experts Meeting on Cancer Science & Therapy during April 29-30, 2019 at Seoul, South Korea; World Congress on Radiology and Oncology during April 08-09, 2019 at Abu Dhabi, UAE; Annual meeting on Women’s cancer at Honolulu, Hawaii during March 16-19, 2019; Clinical Immuno-Oncology Symposium during February 28-March 02, 2019 at California, USA; Annual Conference: Clinical Hematology & Oncology 2019 during February 16-19, 2019 at San Diego, USA; International Conference on Cancer Research and Pharmacology during March 11-12, 2019 at Singapore; International Conference on Clinical Oncology and Molecular Diagnostics during June 17-18, 2019 at Rome, Italy

Related Cancer Institutions:

ESO - European School of Oncology; Kharkiv National Medical University; Medical University – Plovdiv; Medical University – Pleven; Bukovinian State Medical University; Technical University of Munich; University of Berlin; University of Amsterdam; Erasmus University Rotterdam; Leiden UniversityRWTH Aachen University; University of Groningen; Utrecht University; University of Tübingen; Yerevan State Medical University; University of Copenhagen; Maastricht University; Medical University of Vienna; University of Milan; University of Barcelona

Track 2: Neurological Cancer:

There are numerous kinds of mind and spinal string tumors. The tumors are shaped by the anomalous development of cells and may start in various parts of the mind or spinal line. Together, the mind and spinal rope make up the focal sensory system. Benign (not malignancy) tumors develop and push on close-by zones of the cerebrum. They once in a while spread into other tissues. Malignant tumors develop rapidly and spread into other mind tissue. A metastatic tumor begins in another piece of the body and spreads to the mind. Tumors that begin in the mind are called essential cerebrum tumors. Metastatic mind tumors are more typical than essential cerebrum tumors.

Related Conferences: Oncology Symposium | Oncology Conferences | Oncology Meetings | Oncology Congress  | Neurological Cancer Conferences | Oncologists Meetings

Global Summit on Oncology & Cancer during May 6-7, 2019 at Tokyo, Japan; 15th World Congress on Blood Cancer during May 09-10, 2019 at Amsterdam, Netherlands; International conference on Cancer Science and Diagnostics during May 13-14, 2019 at Osaka, Japan; International Conference on Oncodiagnostics and Cancer Research during June 17-18, 2019 at Brisbane, Australia; Euro-Global Summit on Cancer Therapy & Radiation Oncology during July 25-27, 2019 at London, UK; European Multidisciplinary Colorectal Cancer Congress during March 9-11, 2019 at Lisbon, Portugal; Pediatric CNS Tumors in the Molecular Era on March 08, 2019 at New York, USA; Annual Miami Breast Cancer Conference during March 07-10, 2019 at Florida, USA; American Association for Cancer Research during March 29-April 03, 2019 at Georgia, USA; Tracking Cancer: Detection and Monitoring from Diagnosis to Therapy during February 04–06, 2019 at Barcelona, Spain

Related Cancer Institutions:

Stanford University; Johns Hopkins School of Medicine; UCSF School of Medicine; Duke University ; Yale School of Medicine; Harvard Medical School; UNC School of Medicine; UT Southwestern Medical School; The University of Chicago Pritzker School of Medicine; Maryland School of Medicine; University of Cincinnati Academic Health Center; University of Wisconsin School of Medicine; University of Minnesota Medical School; Stony Brook School of Medicine; Vermont College of Medicine; Wayne State School of Medicine; Emory University: School of Medicine; University of Utah School of Medicine; Vanderbilt University; Penn State Hershey College of Medicine; Alabama School of Medicine; UMASS School of Medicine; Rutgers New Jersey Medical School; Oklahoma College of Medicine

Track 3: Oropharyngeal Cancer:

Oropharyngeal disease begins inside the piece of the throat specifically behind the nose. This territory encourages you talk and swallow. The most widely recognized sort of Oropharyngeal tumor is squamous cell malignancy of the oropharynx. Oropharyngeal squamous cell carcinoma alludes to growth of the tonsil, base and back 33% of the tongue, delicate sense of taste, and back and parallel pharyngeal dividers. Squamous cell carcinoma involves more than 95% of Oropharyngeal growths.

Related Conferences: Oncology Symposium | Oncology Conferences | Oncology Meetings | Oncology Congress  | Oropharyngeal Cancer Conferences | Oncologists Meetings

World Oncologists Annual Conference on Medical Oncology, Radiation Oncology & Surgical Oncology during December 07-08, 2018 at Chicago, Illinois, USA; Global Meeting on Clinical Oncology and Radiology during March 27-28, 2019 at Hong Kong; Cancer Genomics Congress: New Era for Cancer Prevention during October 21-22, 2019 at Abu Dhabi, UAE; International Conference on Biomarkers and Cancer Targets during November 18-19, 2019 at Dubai, UAE; Global Annual Oncologists Meeting during April 04-05, 2019 at Auckland, New Zealand; Annual T-cell Lymphoma Forum during January 10 - 12, 2019  at  La Jolla, California; Cancer Research and Radiation Oncology during May 20-22, 2019 at Barcelona, Spain; World Summit on Cancer Research and Therapy during April 19-20, 2019 at Dubai, UAE; European Lung Cancer Congress at Geneva, Switzerland during April 10-13, 2019

Related Cancer Institutions:

University of Tokyo; National University of Singapore; Kyoto University; University of Hong Kong; Peking University; Seoul University; National Taiwan University; Osaka University; Tsinghua University; Duke-NUS Medical School; Asian Medical Institute; International Medical University; Taipei Medical University; Allianze University College of Medical Sciences; Mahidol University; Herat University Faculty of Medicine; Karaganda State Medical University; Perdana University Graduate School of Medicine; Chongjin Medical University; Nanyang Technological University

Track 4: Dermatological Cancer:

Skin growth is the most widely recognized sort of malignancy and usually creates in sun-uncovered regions of skin. The rate is most elevated among outside specialists, sportsmen, and sunbathers and is contrarily identified with the measure of melanin skin pigmentation; reasonable cleaned individuals are generally helpless. Skin growths may likewise create a very long time after restorative x-beams or introduction to cancer-causing agents. The most widely recognized types of skin disease are Squamous cell carcinoma, Basal cell carcinoma and Melanoma.

Related Conferences: Oncology Symposium | Oncology Conferences | Oncology Meetings | Oncology Congress  | Dermatological Cancer Conferences | Oncologists Meetings

Euro Congress on Cancer Science & Cancer Therapy during March 07-08, 2019 at Barcelona, Spain; World Conference on Medical Oncology & Hematology during March 27-28, 2019 at Hong Kong; World Congress on Neonatal & Pediatric Oncology during April 1-2, 2019 at Auckland, New Zealand; Global Experts Meeting on Cancer Science & Therapy during April 29-30, 2019 at Seoul, South Korea; World Congress on Radiology and Oncology during April 08-09, 2019 at Abu Dhabi, UAE; Annual meeting on Women’s cancer at Honolulu, Hawaii during March 16-19, 2019; Clinical Immuno-Oncology Symposium during February 28-March 02, 2019 at California, USA; Annual Conference: Clinical Hematology & Oncology 2019 during February 16-19, 2019 at San Diego, USA; International Conference on Cancer Research and Pharmacology during March 11-12, 2019 at Singapore; International Conference on Clinical Oncology and Molecular Diagnostics during June 17-18, 2019 at Rome, Italy

Related Cancer Institutions:

ESO - European School of Oncology; Kharkiv National Medical University; Medical University – Plovdiv; Medical University – Pleven; Bukovinian State Medical University; Technical University of Munich; University of Berlin; University of Amsterdam; Erasmus University Rotterdam; Leiden UniversityRWTH Aachen University; University of Groningen; Utrecht University; University of Tübingen; Yerevan State Medical University; University of Copenhagen; Maastricht University; Medical University of Vienna; University of Milan; University of Barcelona

Track 5: Blood Cancer and Bone Cancer:

They are the three major types of blood cancer. Leukemia is the type of cancer is caused by the rapid production of abnormal blood cells in the bone marrow. These abnormal blood cells affect the bone marrow's ability of the production of red blood cells and platelets. Lymphoma is the type of blood cancer affects the lymphatic system, which is responsible for the removal of excess fluids from your body and producing immune cells. Lymphocytes are a type of white blood cell that fights infection. Abnormal lymphocytes become lymphoma cells, which grow uncontrollably in your lymph nodes and other tissues. Myeloma is the type of blood cancer affects the plasma cells, which are white blood cells responsible for the production of disease-fighting antibodies in the body. Myeloma affects the production of plasma cells which results in weak immune system.

Bone disease is a dangerous tumor that emerges from the cells that make up the bones of the body. This is otherwise called essential bone malignancy. Essential bone tumors will be tumors that emerge in the bone tissue itself, and they might be generous or harmful bone malignancy. Considerate tumors in the bones are more typical than bone growths. Truth be told, when malignancy is distinguished in bone, it regularly is a metastasis that has begun in another organ or part of the body and afterward spread to the bones. This malignancy that has metastasized deep down is named for the site where the first growth started. Bosom, prostate, and lung tumors are among the kinds of growths that normally spread deep down in their propelled stages. Less usually, malignancy can start inside the bone as essential disease of the bone, and this is genuine bone growth. Essential and metastatic optional bone tumors are frequently treated diversely and have an alternate guess.

Related Conferences: Oncology Symposium | Oncology Conferences | Oncology Meetings | Oncology Congress  | Blood Cancer Conferences | Oncologists MeetingsBone Cancer Conferences

Global Summit on Oncology & Cancer during May 6-7, 2019 at Tokyo, Japan; 15th World Congress on Blood Cancer during May 09-10, 2019 at Amsterdam, Netherlands; International conference on Cancer Science and Diagnostics during May 13-14, 2019 at Osaka, Japan; International Conference on Oncodiagnostics and Cancer Research during June 17-18, 2019 at Brisbane, Australia; Euro-Global Summit on Cancer Therapy & Radiation Oncology during July 25-27, 2019 at London, UK; European Multidisciplinary Colorectal Cancer Congress during March 9-11, 2019 at Lisbon, Portugal; Pediatric CNS Tumors in the Molecular Era on March 08, 2019 at New York, USA; Annual Miami Breast Cancer Conference during March 07-10, 2019 at Florida, USA; American Association for Cancer Research during March 29-April 03, 2019 at Georgia, USA; Tracking Cancer: Detection and Monitoring from Diagnosis to Therapy during February 04–06, 2019 at Barcelona, Spain

Related Cancer Institutions:

Stanford University; Johns Hopkins School of Medicine; UCSF School of Medicine; Duke University ; Yale School of Medicine; Harvard Medical School; UNC School of Medicine; UT Southwestern Medical School; The University of Chicago Pritzker School of Medicine; Maryland School of Medicine; University of Cincinnati Academic Health Center; University of Wisconsin School of Medicine; University of Minnesota Medical School; Stony Brook School of Medicine; Vermont College of Medicine; Wayne State School of Medicine; Emory University: School of Medicine; University of Utah School of Medicine; Vanderbilt University; Penn State Hershey College of Medicine; Alabama School of Medicine; UMASS School of Medicine; Rutgers New Jersey Medical School; Oklahoma College of Medicine

Track 6: Lung Cancer:

Lung growth is the main source of disease passings in the two men and ladies in the U.S. also, around the world. The two kinds of lung tumor, which develop and spread in an unexpected way, they are small cell lung diseases (SCLC) and non-small cell lung growths (NSCLC). The phase of lung tumor alludes to the degree to which the malignancy has spread in the body. Treatment of lung disease can include a mix of surgery, chemotherapy, directed treatment, immunotherapy, and radiation treatment and fresher test strategies. Smoking suspension is the most imperative measure that can keep the improvement of lung disease.

Related Conferences: Oncology Symposium | Oncology Conferences | Oncology Meetings | Oncology Congress  | Lung Cancer Conferences | Oncologists Meetings

World Oncologists Annual Conference on Medical Oncology, Radiation Oncology & Surgical Oncology during December 07-08, 2018 at Chicago, Illinois, USA; Global Meeting on Clinical Oncology and Radiology during March 27-28, 2019 at Hong Kong; Cancer Genomics Congress: New Era for Cancer Prevention during October 21-22, 2019 at Abu Dhabi, UAE; International Conference on Biomarkers and Cancer Targets during November 18-19, 2019 at Dubai, UAE; Global Annual Oncologists Meeting during April 04-05, 2019 at Auckland, New Zealand; Annual T-cell Lymphoma Forum during January 10 - 12, 2019  at  La Jolla, California; Cancer Research and Radiation Oncology during May 20-22, 2019 at Barcelona, Spain; World Summit on Cancer Research and Therapy during April 19-20, 2019 at Dubai, UAE; European Lung Cancer Congress at Geneva, Switzerland during April 10-13, 2019

Related Cancer Institutions:

University of Tokyo; National University of Singapore; Kyoto University; University of Hong Kong; Peking University; Seoul University; National Taiwan University; Osaka University; Tsinghua University; Duke-NUS Medical School; Asian Medical Institute; International Medical University; Taipei Medical University; Allianze University College of Medical Sciences; Mahidol University; Herat University Faculty of Medicine; Karaganda State Medical University; Perdana University Graduate School of Medicine; Chongjin Medical University; Nanyang Technological University

Track 7: Renal Cancer and Hepatocellular Cancer:

Renal cell carcinoma (RCC) is also called hypernephroma, renal adenocarcinoma, or renal or kidney cancer. It’s the most common kind of kidney cancer found in adults. The kidneys are organs in your body that help get rid of waste while also regulating fluid balance. There are tiny tubes in the kidneys called tubules. These help filter the blood, aid in excreting waste, and help make urine. RCC occurs when cancer cells start growing uncontrollably in the lining of the tubules of the kidney. RCC is a fast-growing cancer and often spreads to the lungs and surrounding organs.

Hepatocellular carcinoma (HCC) is the most widely recognized sort of essential liver malignancy. Hepatocellular carcinoma happens regularly in individuals with interminable liver maladies, for example, cirrhosis caused by HepatitisB or hepatitis C disease. Cholangiocarcinoma happens in the little, tube-like bile pipes inside the liver that conveys bile to the gallbladder. Cholangiocarcinoma represent 10-20 per cent of every liver malignancy. Intrahepatic bile pipe disease starts in channels inside the liver. Extra hepatic bile channel growth creates in pipes outside of the liver.

Related Conferences: Oncology Symposium | Oncology Conferences | Oncology Meetings | Oncology Congress  | Renal Cancer Conferences | Oncologists MeetingsHepatocellular Cancer Conferences

Euro Congress on Cancer Science & Cancer Therapy during March 07-08, 2019 at Barcelona, Spain; World Conference on Medical Oncology & Hematology during March 27-28, 2019 at Hong Kong; World Congress on Neonatal & Pediatric Oncology during April 1-2, 2019 at Auckland, New Zealand; Global Experts Meeting on Cancer Science & Therapy during April 29-30, 2019 at Seoul, South Korea; World Congress on Radiology and Oncology during April 08-09, 2019 at Abu Dhabi, UAE; Annual meeting on Women’s cancer at Honolulu, Hawaii during March 16-19, 2019; Clinical Immuno-Oncology Symposium during February 28-March 02, 2019 at California, USA; Annual Conference: Clinical Hematology & Oncology 2019 during February 16-19, 2019 at San Diego, USA; International Conference on Cancer Research and Pharmacology during March 11-12, 2019 at Singapore; International Conference on Clinical Oncology and Molecular Diagnostics during June 17-18, 2019 at Rome, Italy

Related Cancer Institutions:

ESO - European School of Oncology; Kharkiv National Medical University; Medical University – Plovdiv; Medical University – Pleven; Bukovinian State Medical University; Technical University of Munich; University of Berlin; University of Amsterdam; Erasmus University Rotterdam; Leiden UniversityRWTH Aachen University; University of Groningen; Utrecht University; University of Tübingen; Yerevan State Medical University; University of Copenhagen; Maastricht University; Medical University of Vienna; University of Milan; University of Barcelona

Track 8: Breast Oncology:

Breast growth begins when cells in the bosom start to become wild. These cells generally shape a tumor that can frequently be seen on x-beam or felt as an irregularity. The tumor is harmful if the cells can develop into encompassing tissues or spread far off regions of the body. Breast tumor happens altogether in ladies, yet men can get bosom tumor, as well. On the off chance that tumor cells have spread to your lymph nodes, there is a higher possibility that the cells could have gone through the lymph framework and spread to different parts of your body. The more lymph hubs with breast malignancy cells, the more probable it is that the disease might be found in different organs. Along these lines, discovering growth in at least one lymph node regularly influences your treatment design. For the most part, you will require surgery to expel at least one lymph node to know whether the disease has spread. All things considered, not all ladies with malignancy cells in their lymph hubs create metastases, and a few ladies with no disease cells in their lymph nodes create metastases later.

Related Conferences: Oncology Symposium | Oncology Conferences | Oncology Meetings | Oncology Congress  | Breast Cancer Conferences | Oncologists Meetings

Global Summit on Oncology & Cancer during May 6-7, 2019 at Tokyo, Japan; 15th World Congress on Blood Cancer during May 09-10, 2019 at Amsterdam, Netherlands; International conference on Cancer Science and Diagnostics during May 13-14, 2019 at Osaka, Japan; International Conference on Oncodiagnostics and Cancer Research during June 17-18, 2019 at Brisbane, Australia; Euro-Global Summit on Cancer Therapy & Radiation Oncology during July 25-27, 2019 at London, UK; European Multidisciplinary Colorectal Cancer Congress during March 9-11, 2019 at Lisbon, Portugal; Pediatric CNS Tumors in the Molecular Era on March 08, 2019 at New York, USA; Annual Miami Breast Cancer Conference during March 07-10, 2019 at Florida, USA; American Association for Cancer Research during March 29-April 03, 2019 at Georgia, USA; Tracking Cancer: Detection and Monitoring from Diagnosis to Therapy during February 04–06, 2019 at Barcelona, Spain

Related Cancer Institutions:

Stanford University; Johns Hopkins School of Medicine; UCSF School of Medicine; Duke University ; Yale School of Medicine; Harvard Medical School; UNC School of Medicine; UT Southwestern Medical School; The University of Chicago Pritzker School of Medicine; Maryland School of Medicine; University of Cincinnati Academic Health Center; University of Wisconsin School of Medicine; University of Minnesota Medical School; Stony Brook School of Medicine; Vermont College of Medicine; Wayne State School of Medicine; Emory University: School of Medicine; University of Utah School of Medicine; Vanderbilt University; Penn State Hershey College of Medicine; Alabama School of Medicine; UMASS School of Medicine; Rutgers New Jersey Medical School; Oklahoma College of Medicine

Track 9: Pancreatic Cancer and Colorectal Cancer:

Pancreatic growth normally spreads quickly to adjacent organs. It is at times identified in its beginning periods. Be that as it may, for individuals with pancreatic pimples or a family history of pancreatic tumor, some screening advances may help identify an issue early. One indication of pancreatic tumor is diabetes, particularly when it happens with weight reduction, jaundice or agony in the upper mid-region that spreads to the back. Pancreatic growth happens when cells in your pancreas create changes in their DNA. These changes make cells develop wildly and to keep living after ordinary cells would bite the dust. These amassing cells can shape a tumor. Untreated pancreatic malignancy spreads to adjacent organs and veins. Most pancreatic disease starts in the cells that line the pipes of the pancreas. This kind of tumor is called pancreatic adenocarcinoma or pancreatic exocrine growth. Once in a while, growth can frame in the hormone-delivering cells or the neuroendocrine cells of the pancreas. These sorts of malignancy are called islet cell tumors, pancreatic endocrine growth and pancreatic neuroendocrine tumors.

Colorectal disease happens when tumors frame in the coating of the digestive organ. It is basic in the two men and ladies. The danger of creating colorectal malignancy ascends after age 50. You're likewise more inclined to get it in the event that you have colorectal polyps, a family history of colorectal tumor, ulcerative colitis or Crohn's malady, eat an eating regimen high in fat, or smoke. The most widely recognized types of acquired colon growth disorders are: Hereditary Non Polyposis Colorectal Malignancy (HNPCC) and Familial adenomatous polyposis (FAP).

Related Conferences: Oncology Symposium | Oncology Conferences | Oncology Meetings | Oncology Congress  | Pancreatic Cancer Conferences | Oncologists MeetingsColorectal Cancer Conferences

World Oncologists Annual Conference on Medical Oncology, Radiation Oncology & Surgical Oncology during December 07-08, 2018 at Chicago, Illinois, USA; Global Meeting on Clinical Oncology and Radiology during March 27-28, 2019 at Hong Kong; Cancer Genomics Congress: New Era for Cancer Prevention during October 21-22, 2019 at Abu Dhabi, UAE; International Conference on Biomarkers and Cancer Targets during November 18-19, 2019 at Dubai, UAE; Global Annual Oncologists Meeting during April 04-05, 2019 at Auckland, New Zealand; Annual T-cell Lymphoma Forum during January 10 - 12, 2019  at  La Jolla, California; Cancer Research and Radiation Oncology during May 20-22, 2019 at Barcelona, Spain; World Summit on Cancer Research and Therapy during April 19-20, 2019 at Dubai, UAE; European Lung Cancer Congress at Geneva, Switzerland during April 10-13, 2019

Related Cancer Institutions:

University of Tokyo; National University of Singapore; Kyoto University; University of Hong Kong; Peking University; Seoul University; National Taiwan University; Osaka University; Tsinghua University; Duke-NUS Medical School; Asian Medical Institute; International Medical University; Taipei Medical University; Allianze University College of Medical Sciences; Mahidol University; Herat University Faculty of Medicine; Karaganda State Medical University; Perdana University Graduate School of Medicine; Chongjin Medical University; Nanyang Technological University

Track 10: Reproductive Cancers:

Cervical tumor is a standout amongst the most preventable of all diseases. It is caused by specific sorts of the human papillomavirus (HPV).Having consistent cervical spread tests is a lady's best assurance against creating cervical growth. This test will help discover unusual changes in the cells of the cervix. Penile tumor is an uncommon condition which happens when destructive cells frame in the tissue of the penis. Uncircumcised men beyond 50 years old are most in danger of getting penile disease. Men with a background marked by genital warts and human papillomavirus (HPV) are likewise at higher hazard. Testicular malignancy is the most widely recognized tumor in men matured in the vicinity of 15 and 35 years however it can happen to men of all ages. Testicular tumor is quite often reparable, especially on the off chance that it is analysed and treated at a beginning time.

Related Conferences: Oncology Symposium | Oncology Conferences | Oncology Meetings | Oncology Congress  | Reproductive Cancer Conferences | Oncologists Meetings

Euro Congress on Cancer Science & Cancer Therapy during March 07-08, 2019 at Barcelona, Spain; World Conference on Medical Oncology & Hematology during March 27-28, 2019 at Hong Kong; World Congress on Neonatal & Pediatric Oncology during April 1-2, 2019 at Auckland, New Zealand; Global Experts Meeting on Cancer Science & Therapy during April 29-30, 2019 at Seoul, South Korea; World Congress on Radiology and Oncology during April 08-09, 2019 at Abu Dhabi, UAE; Annual meeting on Women’s cancer at Honolulu, Hawaii during March 16-19, 2019; Clinical Immuno-Oncology Symposium during February 28-March 02, 2019 at California, USA; Annual Conference: Clinical Hematology & Oncology 2019 during February 16-19, 2019 at San Diego, USA; International Conference on Cancer Research and Pharmacology during March 11-12, 2019 at Singapore; International Conference on Clinical Oncology and Molecular Diagnostics during June 17-18, 2019 at Rome, Italy

Related Cancer Institutions:

ESO - European School of Oncology; Kharkiv National Medical University; Medical University – Plovdiv; Medical University – Pleven; Bukovinian State Medical University; Technical University of Munich; University of Berlin; University of Amsterdam; Erasmus University Rotterdam; Leiden UniversityRWTH Aachen University; University of Groningen; Utrecht University; University of Tübingen; Yerevan State Medical University; University of Copenhagen; Maastricht University; Medical University of Vienna; University of Milan; University of Barcelona

Track 11: Cancer Therapy:

Malignancy treatment portrays the treatment of tumor in a patient, regularly with surgery, chemotherapy or potentially radiotherapy. Directed treatments are likewise accessible for some disease composes. A malignancy patient may get a wide range of kinds of treatment, including those went for mitigating the manifestations of disease, for example, torment. Chemotherapy as a rule alludes to the utilization of pharmaceuticals or medications to treat disease. The possibility of having chemotherapy panics numerous individuals. Be that as it may, realizing what chemotherapy is, the manner by which it works, and what's in store can frequently help quiet your feelings of trepidation. It can likewise give you a superior feeling of control over your disease treatment. Directed treatment is a unique sort of chemotherapy that exploits contrasts between typical cells and malignancy cells. It's occasionally utilized alone, however frequently other malignancy medications are utilized with focused treatment.

Related Conferences: Oncology Symposium | Oncology Conferences | Oncology Meetings | Oncology Congress  | Cancer Therapy Conferences | Oncologists Meetings

Global Summit on Oncology & Cancer during May 6-7, 2019 at Tokyo, Japan; 15th World Congress on Blood Cancer during May 09-10, 2019 at Amsterdam, Netherlands; International conference on Cancer Science and Diagnostics during May 13-14, 2019 at Osaka, Japan; International Conference on Oncodiagnostics and Cancer Research during June 17-18, 2019 at Brisbane, Australia; Euro-Global Summit on Cancer Therapy & Radiation Oncology during July 25-27, 2019 at London, UK; European Multidisciplinary Colorectal Cancer Congress during March 9-11, 2019 at Lisbon, Portugal; Pediatric CNS Tumors in the Molecular Era on March 08, 2019 at New York, USA; Annual Miami Breast Cancer Conference during March 07-10, 2019 at Florida, USA; American Association for Cancer Research during March 29-April 03, 2019 at Georgia, USA; Tracking Cancer: Detection and Monitoring from Diagnosis to Therapy during February 04–06, 2019 at Barcelona, Spain

Related Cancer Institutions:

Stanford University; Johns Hopkins School of Medicine; UCSF School of Medicine; Duke University ; Yale School of Medicine; Harvard Medical School; UNC School of Medicine; UT Southwestern Medical School; The University of Chicago Pritzker School of Medicine; Maryland School of Medicine; University of Cincinnati Academic Health Center; University of Wisconsin School of Medicine; University of Minnesota Medical School; Stony Brook School of Medicine; Vermont College of Medicine; Wayne State School of Medicine; Emory University: School of Medicine; University of Utah School of Medicine; Vanderbilt University; Penn State Hershey College of Medicine; Alabama School of Medicine; UMASS School of Medicine; Rutgers New Jersey Medical School; Oklahoma College of Medicine

Track 12: Cancer Scenario:

Growth biomarkers can be DNA, mRNA, proteins, metabolites, or procedures, for example, apoptosis, angiogenesis or expansion. The markers are created either by the tumor itself or by different tissues, in light of the nearness of disease or other related conditions, for example, irritation. Such biomarkers can be found in an assortment of liquids, tissues and cell lines. Biomarkers that Support a Treatment's Cellular or Molecular Action and furthermore they can Detect and Measure to Develop a Personalized Anticancer Treatment Plan.

Related Conferences: Oncology Symposium | Oncology Conferences | Oncology Meetings | Oncology Congress  | Cancer Conferences | Oncologists Meetings

World Oncologists Annual Conference on Medical Oncology, Radiation Oncology & Surgical Oncology during December 07-08, 2018 at Chicago, Illinois, USA; Global Meeting on Clinical Oncology and Radiology during March 27-28, 2019 at Hong Kong; Cancer Genomics Congress: New Era for Cancer Prevention during October 21-22, 2019 at Abu Dhabi, UAE; International Conference on Biomarkers and Cancer Targets during November 18-19, 2019 at Dubai, UAE; Global Annual Oncologists Meeting during April 04-05, 2019 at Auckland, New Zealand; Annual T-cell Lymphoma Forum during January 10 - 12, 2019  at  La Jolla, California; Cancer Research and Radiation Oncology during May 20-22, 2019 at Barcelona, Spain; World Summit on Cancer Research and Therapy during April 19-20, 2019 at Dubai, UAE; European Lung Cancer Congress at Geneva, Switzerland during April 10-13, 2019

Related Cancer Institutions

University of Tokyo; National University of Singapore; Kyoto University; University of Hong Kong; Peking University; Seoul University; National Taiwan University; Osaka University; Tsinghua University; Duke-NUS Medical School; Asian Medical Institute; International Medical University; Taipei Medical University; Allianze University College of Medical Sciences; Mahidol University; Herat University Faculty of Medicine; Karaganda State Medical University; Perdana University Graduate School of Medicine; Chongjin Medical University; Nanyang Technological University

Track 13: Nursing Oncology:

An Oncology Nurse gives care to growth patients and those in danger for getting the sickness. They screen physical conditions, recommend solution, and oversee chemotherapy and different medications. Oncology is a standout amongst the most difficult and remunerating fields in nursing. One of the essential parts of the oncology nurture is quiet appraisal. They are in charge of surveying patients who have introduced because of treatment reactions, and also evaluating patients, amid and post-chemotherapy. The oncology nurture must have the capacity to comprehend pathology comes about and their suggestions, and have an inside and out learning of the normal symptoms of growth medicines. The oncology nurture should likewise utilize her relational aptitudes to tune in to the patient, surveying their comprehension of the malady and its procedure and also the patient's passionate state.

Related Conferences: Oncology Symposium | Oncology Conferences | Oncology Meetings | Oncology Congress  | Cancer Conferences | Oncologists Meetings

Euro Congress on Cancer Science & Cancer Therapy during March 07-08, 2019 at Barcelona, Spain; World Conference on Medical Oncology & Hematology during March 27-28, 2019 at Hong Kong; World Congress on Neonatal & Pediatric Oncology during April 1-2, 2019 at Auckland, New Zealand; Global Experts Meeting on Cancer Science & Therapy during April 29-30, 2019 at Seoul, South Korea; World Congress on Radiology and Oncology during April 08-09, 2019 at Abu Dhabi, UAE; Annual meeting on Women’s cancer at Honolulu, Hawaii during March 16-19, 2019; Clinical Immuno-Oncology Symposium during February 28-March 02, 2019 at California, USA; Annual Conference: Clinical Hematology & Oncology 2019 during February 16-19, 2019 at San Diego, USA; International Conference on Cancer Research and Pharmacology during March 11-12, 2019 at Singapore; International Conference on Clinical Oncology and Molecular Diagnostics during June 17-18, 2019 at Rome, Italy

Related Cancer Institutions:

ESO - European School of Oncology; Kharkiv National Medical University; Medical University – Plovdiv; Medical University – Pleven; Bukovinian State Medical University; Technical University of Munich; University of Berlin; University of Amsterdam; Erasmus University Rotterdam; Leiden UniversityRWTH Aachen University; University of Groningen; Utrecht University; University of Tübingen; Yerevan State Medical University; University of Copenhagen; Maastricht University; Medical University of Vienna; University of Milan; University of Barcelona

Market Analysis

Global Oncology or the Cancer Drugs Market is relied upon to gather $111.9 billion by 2020, enrolling a CAGR of 7.1% amid the gauge time frame 2014 to 2020. Late advance in organic treatments has augmented the size of remedial focuses for treatment of disease with the distinguishing proof of tumor cell particular qualities. Immunotherapies/biologics are developing as potential treatments to locate the lasting cure for different disease sorts. Among different biologics, drugs in view of monoclonal antibodies (mAbs) have increased noteworthy consideration as of late because of their high viability.

Worldwide disease drugs advertise represented $78,238.9 million of every 2015. The disease drugs showcase is driven by the developing commonness of different sorts of malignancy, expanding interest of natural and focused on tranquilize treatments, ceaseless patent expiry of key growth drugs and the rising effect of biosimilars. Be that as it may, the high cost of medication advancement, the danger of disappointment and the unfriendly impacts of tumor sedate treatment, especially chemotherapy, blocks the market development. Created countries have actualized strict directions for the outline and improvement of malignancy drugs. USFDA and European Union have attempted noteworthy activities to fuel the development of the disease drugs advertise by giving pre-showcase endorsement to potential medications under clinical improvement. Asia-Pacific and LAMEA are promising locales for directing clinical trials due a huge populace base and the minimal effort of clinical trials when contrasted with North America and Europe. By and by, progression of malignancy sedate research inferable from organic/directed treatments and customized medications hold promising open doors for pharmaceutical, bio-pharmaceutical and biotechnology organizations occupied with creating tumor drugs.

Why Singapore???

Two cancers have been rising sharply in Singapore: breast cancer in women and prostate cancer in men.

Over the past 40 years, the incidence of breast cancer here has more than doubled - from 25 to 65 per 100,000 women. Over the same period, prostate cancer has gone up fivefold - from six to 30 per 100,000 men.

For women, breast cancer is not just the most common cancer, accounting for one in three cancers in women, but it is also the top killer.

The latest cancer registry report released last month showed that 2,105 women died of breast cancer between 2011 and 2015. More than half the women were diagnosed between the age of 45 and 64 years.

The good news is that 71 per cent were diagnosed in the early stages, giving them a high chance of survival. Those in stage 1 have a 91 per cent chance of surviving beyond five years, compared with 20 per cent for those discovered at stage 4.

The report said: "There was a significant increase in the survival of breast cancer patients from the period 2006-2010 to 2011-2015, likely due to improvements in treatment regimes."

A total of 14,148 people were diagnosed with cancer in 2015, up from 11,758 in 2011.

The Singapore Government is supporting to develop industry-independent cancer clinical trials. The following are the National Cancer Cooperative Trials Groups in Singapore.

Funds Providing Organizations:

  • American Brain Tumor Association (ABTA)
  • ACT Brain Tumor
  • Ben and Catherine Ivy Foundation
  • Brain Tumor Foundation of Canada (BTFC)
  • Brain Tumor Funder's Collaborative
  • Childhood Brain Tumor Foundation
  • Concern Foundation
  • Congressionally Directed Medical Research Programs
  • Gold Hirsh Foundation
  • Grey Ribbon Crusade
  • Matthew Larson Foundation
  • National Brain Tumor Society
  • NBTS & AANS/CNS Section on Tumors
  • Pediatric Brain Tumor Foundation
  • Pediatric Oncology Grants\
  • Sontag Foundation

Key Market Players across the Globe:

  •     AstraZeneca
  •     Antisense Pharma
  •     EMD Serono Inc
  •     GlaxoSmithKline
  •     Bristol-Myers Squibb
  •     Pfizer Inc.
  •     F. Hoffmann-La Roche Ltd  Novartis AG

Conference highlights:

  • Pathophysiology of Cancer
  • Neurological Cancer
  • Oropharyngeal Cancer
  • Blood and Bone Cancer
  • Lung cancer
  • Renal and Hepatocellular cancer
  • Breast Oncology
  • Pancreatic and Colorectal Cancer
  • Reproductive Cancers
  • Cancer Therapy
  • Cancer Screening & Diagnosis
  • Cancer: Innovations
  • Nursing Oncology

Major Cancer Associations across the Globe:

  • American Association for cancer research
  • American Neuroma Association
  • Cancer Research Institute
  • National Cancer Society of Malaysia
  • National Cancer Institute
  • Cancer Research UK
  • Association of oncology Social work
  • The Association for Cancer Surgery (BASO)
  • Global Initiative against HPV and Cervical Cancer       
  • Global Lung Cancer Coalition (GLCC)
  • International Gynecologic Cancer Society
  • Cancer Council Australia
  • Australian Cancer Research Foundation
  • Australian Cancer Foundation
  • Prostate Cancer Foundation of Australia
  • National Breast Cancer Foundation
  • Kids with Cancer Foundation
  • Australian Cervical Cancer Foundation
  • Cure Cancer Australia Foundation
  • Clinical Oncology Society of Australia
  • Children’s Cancer Foundation
  • Australian Gynaecological Cancer Foundation
  • Cure Brain Cancer Foundation
  • Cancer Associations in Japan:
  • Sapporo Cancer Seminar Foundation
  • Japanese Breast Cancer Society
  • Japan Society of Gynecologic Oncology
  • Japan Society of Clinical Oncology
  • Japan Lung Cancer Society
  • Japan Society for Neuro-Oncology
  • Chiba Cancer Center
  • Aichi Cancer Center
  • Higashi Sapporo Hospital
  • Tochigi Cancer Center
  • Kanagawa Cancer Centre
  • Shizuoka Cancer Center
  • Japanese Association of Cancer Registries
  • Lung Oncology Group in Kyushu
  • Japanese Foundation for Cancer Research

Statistical Analysis of cancer types:

Target Audience: Oncologists, Researchers, Academicians, Physicians, Post Docs, Students, Pharmacy Industries, Academic scientists, Industry professionals, Diagnostic laboratory professionals.

Top Cancer Centres in Singapore:

Cancer treatment centres in Singapore are generally located in both public and private hospitals. These units and medical centres specialise in the treatment of cancer (oncology).

  • Singapore Cancer Society
  • Raffles Hospital
  • Parkway East Hospital - Parkway Cancer Centre
  • Gleneagles Hospital - Parkway Cancer Centre
  • Tan Tock Seng Hospital
  • Singapore General Hospital
  • KK Women's and Children's Hospital
  • Mount Elizabeth Hospital - Parkway Cancer Centre
  • National Cancer Centre
  • National University Hospital
  • Changi General Hospital
  • National University Hospital
  • Ng Teng Fong General Hospital and Jurong Community Hospital
  • National University Cancer Institute, Singapore
  • National University Heart Centre, Singapore
  • National University Centre for Oral Health, Singapore (2019)
  • National University Polyclinics
  • Jurong Medical Centre

In 2010, the worldwide disease market was esteemed at $64 billion, with estimated Compound Annual Growth Rate development to $81 billion by 2016. The seven noteworthy disease markets (US, France, Malaysia, Italy, Spain, United Kingdom and Japan) spoke to ~69% of the 2010 worldwide tumor showcase ($43 billion). The US overwhelmed 2010 deals with a piece of the overall industry of 39.5% and the main ten organizations of the worldwide growth showcase spoke to 88.1% of the aggregate market.

The market esteem in Malaysia is worth $42 million, and development will be driven by malignancy treatment taking after early determination of growths and focused on treatment in the three noteworthy diseases - lung, bosom and colorectal. The Asia oncology medicate advertise incomes have developed at a CAGR of 3.3% from 2009-2014. Asia oncology sedate market will develop at an impressive CAGR and will surpass over USD 20 billion by 2017.

Market Value for Cancer Research in billion $

In light of innovation, the malignancy diagnostics market is sorted into stage based and instrument-based. The instrument-based portion is relied upon to represent a noteworthy share of the disease diagnostics showcase, by item, in 2015.

This report contemplates the worldwide disease diagnostics showcase for the estimate time of 2015 to 2020. This market is relied upon to reach $12.1 Billion by 2020 from $8.1 Billion in 2015 and is ready to develop at a CAGR of 11.9% amid the gauge time frame.

Past Conference Report

Asia Pacific Oncologists 2018

Conference Series LLC Ltd successfully anchored its leading "15th Asia Pacific Oncologists Annual Meeting" slated during September 05-06, 2018 at Radisson Hotel Narita in Tokyo, Japan.

Asia Pacific Oncologists 2018 is distinguished with the attendance of Editorial Board Members of supported Journals, Scientists, Young and Brilliant Researchers, Business Delegates and Talented Student communities representing more than 25 countries who made this conference rewarding and fecund.

Our 15th Asia Pacific Oncologists Annual Meeting was based on the theme “Towards the Innovations in the Cancer Treatment” which has encrusted the below scientific sessions:

  • Pathophysiology of Cancer
  • Neurological Cancer
  • Oropharyngeal Cancer
  • Dermatological Cancer
  • Blood and Bone Cancer
  • Lung cancer
  • Renal and Hepatocellular cancer
  • Breast Oncology
  • Pancreatic and Colorectal Cancer
  • Reproductive Cancers
  • Cancer Therapy
  • Cancer Scenario
  • Nursing Oncology

The conference received salutations & immense support was extended by the keynote lectures mentioned below:

  • Wassil Nowicky, Ukrainian Anti-Cancer Institute, Austria
  • Kakil Ibrahim Rasul, National Center for Cancer Care and Research, Qatar
  • Jae Pil Hwang, Soonchunhyang University Hospital, Republic of Korea

Conference Series LLC Ltd wishes to acknowledge with its deep sincere gratitude to all the supporters from the Editorial Board Members of our Open Access Journals, Keynote speakers, Valuable speakers, students, delegates for their contribution to make this event a huge success.

We once again thank you all for the enormous exquisite response. This inspires us to continue organizing events and conferences for furthering the Oncology Research. Conference Series LLC Ltd therefore, is glad to announce its 16th Asia Pacific Oncologists Annual Meeting slated during May 13-14, 2019 in Singapore.

 Mark your calendars for the upcoming meeting; we are hoping to see you soon!!!!


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date May 13-14, 2019

Speaker Opportunity

Supported By

Journal of Carcinogenesis & Mutagenesis: Open Access Journal of Cancer Science & Therapy: Open Access Journal of Integrative Oncology: Open Access

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos